- Companies
- Lumitron Technologies
Lumitron Technologies Valuation, Funding & Investors
Lumitron Technologies is valued at $150M as of April 2020.
Last Lumitron Technologies valuation
$150M
Series A · Apr 2020
Last Lumitron Technologies funding round
$70M
Undisclosed stage · Sep 2026
Cumulative funding Lumitron Technologies raised
$179M
across 4 funding rounds
Key investors in Lumitron Technologies
Clinton Capital Partners
Perennial Partners
Vickers Venture Partners
ROTH Capital Partners
Allan Moss
Greyrock Investments
Lumitron Technologies Overview
About Lumitron Technologies
Lumitron Technologies is a developer of compact X-ray imaging systems based on Laser-Compton technology licensed from Lawrence Livermore National Laboratory and SLAC National Accelerator Laboratory. Headquartered in the United States, the company produces devices sized like CT scanners that deliver synchrotron-level resolution at lower cost for hospital diagnostics. Applications target tumor detection with ultra-low radiation doses and integrated precision radiotherapy during imaging.
Founded
2013
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Product sales
Valuation
$150M (Apr 2020)
Lumitron Technologies Valuation
Lumitron Technologies is currently valued at $150M, based on its Series A in April 2020.
The $34M round was led by Vickers Venture Partners, with participation from Clinton Capital Partners, ROTH Capital Partners and Perennial Partners.
Lumitron Technologies' valuation has grown 1.1x from $136M at its undisclosed-stage round in July 2018 to $150M in April 2020, across 2 priced rounds.
Lumitron Technologies valuation by funding round
| Date | Stage | Valuation |
|---|---|---|
| Apr 2020 | Series A | $150M |
| Jul 2018 | Undisclosed stage | $136M |
Lumitron Technologies Funding History
Lumitron Technologies has raised a total of $179M across 4 funding rounds.
Lumitron Technologies' first fundraising round was a $25M undisclosed-stage round in July 2018. The most recent completed round was a $70M undisclosed-stage round in September 2026.
Lumitron Technologies funding rounds
| Date | Stage | Investors | Raised | Valuation | Deal Summary |
|---|---|---|---|---|---|
| Sep 2026 | Undisclosed stage | Clinton Capital Partners | $70M | - | - |
| Jun 2026 | Strategic investment | Hancock Prospecting (lead) | $50M | - | Hancock Prospecting, led by Gina Rinehart, invested US$50 million in Lumitron Technologies on June 25, 2026, securing a strategic investor position and a board seat. The deal includes the right to increase the investment to US$100 million by the end of 2026. The funding supports the commercial scale-up and deployment of Lumitron’s HyperVIEW™ Very High Energy Electron (VHEE) beam and advanced X-ray technology platforms across cancer care, healthcare, mining, and industrial applications. Lumitron’s technology delivers X-rays with up to 1,000 times the resolution of conventional systems, enabling high-resolution imaging for mineral processing and cancer detection. The investment positions Hancock Prospecting as a strategic partner as Lumitron accelerates toward global commercialization, with three machines planned for deployment in Australia. This move follows Hancock Prospecting’s recent US$1 billion stake in SpaceX earlier in June 2026, reflecting its diversification into advanced technologies including artificial intelligence and medical imaging. |
| Apr 2020 | Series A | Vickers Venture Partners (lead); Clinton Capital Partners; ROTH Capital Partners; Perennial Partners | $34M | $150M | Lumitron Technologies is a US-based startup developing the HyperVIEW platform, which consists of laser-based, hyper-precision monochromatic X-ray systems offering up to 1,000 times higher resolution than conventional X-rays with significantly less radiation, applicable in research, medical diagnostics and therapy, industrial non-destructive imaging, 3D printing, mining, security, and semiconductor manufacturing. The technology originated from nearly 20 years of federally funded research at Lawrence Livermore National Laboratory totaling $220 million. On April 28, 2020, Lumitron closed a $34 million Series A funding round led by Vickers Venture Partners, with participation from Clinton Capital Partners, Perennial Partners (or Perennial Value Management), ROTH Capital Partners, and global family offices; investors took common stock with no preferred terms. The round, described as the founder's round, had an estimated $150 million pre-money valuation according to Orange County Business Journal, enabling the company to fast-track development of multiple systems for high-end university research, cancer diagnostics and therapy, and industrial applications, with plans to build first commercial systems in Q4 2020 amid strong interest from universities and government institutions. Lumitron, founded about seven years prior and based in Irvine, California, anticipates this as its final private round before pursuing public markets, leveraging Vickers' expertise in tech investments and IPOs. |
| Jul 2018 | Undisclosed stage | Greyrock Investments; Steve Sargent; Allan Moss; John Egan | $25M | $136M | Lumitron Technologies develops advanced X-ray imaging systems like the HyperVIEW EBCS, offering 100x better resolution and lower radiation than CT scanners, based on technology from Lawrence Livermore National Laboratory, targeting medical, therapeutic, and industrial applications including cellular-level imaging for cancer treatment. |
Who has invested in Lumitron Technologies?
9 investors have backed Lumitron Technologies across its funding rounds, including Clinton Capital Partners, Perennial Partners, Vickers Venture Partners, ROTH Capital Partners, Allan Moss and Greyrock Investments.
Lead investors include Hancock Prospecting and Vickers Venture Partners.
Lumitron Technologies Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 2 | Participant | Apr 2020 | ||
| 1 | Participant | Jul 2018 | ||
| 1 | Participant | Jul 2018 | ||
| 1 | Participant | Jul 2018 | ||
| 1 | Participant | Jul 2018 | ||
| 1 | Lead | Apr 2020 | ||
| 1 | Participant | Apr 2020 | ||
This data is available for Pro users. Sign up to see all 9 Lumitron Technologies investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialLumitron Technologies Competitors
Lumitron Technologies competitors include listed companies like Detection Technology and Allianca Saude, and private ones like Tingsheng Technology, Kanteron Systems, Koning and Qure AI.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $116M | $11M | $128M | 0.9x | ||
| Private | - | - | $152M | - | ||
| Publicly listed | $224M | ($207M) | $103M | - | ||
| Private | - | - | $102M | - | ||
| Private | - | - | $230M | - | ||
| Private | $19M | - | $240M | 12.6x |
Lumitron Technologies Public Comps
Lumitron Technologies is still privately-owned, but its public comps include Lucid Diagnostics, EKF Diagnostics, Detection Technology, Bioneer, Airdoc, Exagen, Scope Fluidics, Eurofins-Cerep, Allianca Saude and Devyser Diagnostics.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $5M | ($58M) | 29.9x | 24.0x | (2.4x) | (2.8x) | |||
| $69M | $17M | 1.9x | 1.8x | 7.8x | 7.3x | |||
| $116M | $11M | 0.9x | 0.9x | 9.6x | 8.1x | |||
| $240M | $16M | 0.8x | - | 12.5x | - | |||
| $26M | ($3M) | 1.5x | 1.5x | (11.9x) | - | |||
| $67M | ($13M) | 2.9x | 2.7x | (14.4x) | (27.4x) | |||
| $26K | ($12M) | 2677.0x | 250.3x | (5.7x) | (4.2x) | |||
| $47M | $7M | 1.7x | - | 11.8x | - | |||
This data is available for Pro users. Sign up to see all Lumitron Technologies competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Lumitron Technologies
| When was Lumitron Technologies founded? | Lumitron Technologies was founded in 2013. |
| Where is Lumitron Technologies headquartered? | Lumitron Technologies is headquartered in Los Angeles, CA, United States. |
| Is Lumitron Technologies publicly listed? | No, Lumitron Technologies is a private, VC-backed company. |
| What is Lumitron Technologies' valuation? | Lumitron Technologies was last valued at $150M in its Series A in April 2020. |
| How much funding has Lumitron Technologies raised? | Lumitron Technologies has raised $179M across 4 funding rounds. |
| What was Lumitron Technologies' last funding round? | Lumitron Technologies' last funding round was a $70M undisclosed-stage round in September 2026. |
| Who are Lumitron Technologies' investors? | Lumitron Technologies' investors include Clinton Capital Partners, Greyrock Investments, Steve Sargent, Allan Moss, John Egan, Vickers Venture Partners, ROTH Capital Partners, Hancock Prospecting and Perennial Partners. |
| Which companies are comparable to Lumitron Technologies? | Companies comparable to Lumitron Technologies include Detection Technology, Tingsheng Technology, Allianca Saude, Kanteron Systems, Koning and Qure AI. |
See companies similar to Lumitron Technologies
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




